Showing results (81-90 of 262) with videos related to
Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
From chemotherapy to targeted treatmentR Dummer, S Rozati, N Eggmann, et al.Therapeutische Umschau. Revue Therapeutique|October 3, 1998
[Therapy of cutaneous melanoma]R Dummer, F O Nestle, G Hofbauer, et al.The British Journal of Dermatology|June 3, 1999
Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndromeT M Fritz, M Kleinhans, F O Nestle, et al.The Journal of Investigative Dermatology|July 1, 1993
Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine productionJ C Becker, A Schwinn, R Dummer, et al.Revue Medicale Suisse|May 12, 2010
[Vitamin D, ultraviolet rays and skin cancer]M-J Barysch, L Feldmeyer, H Bischoff-Ferrari, et al.Seminars in Cutaneous Medicine and Surgery|July 13, 2000
Pathogenesis of cutaneous lymphomasR Dummer, J Willers, J Kamarashev, et al.International Archives of Allergy and Immunology|April 18, 2001
Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophiliaH U Simon, S G Plötz, D Simon, et al.Swiss Medical Weekly|December 20, 2011
Updated Swiss guidelines for the treatment and follow-up of cutaneous melanomaR Dummer, M Guggenheim, A W Arnold, et al.Blood|January 12, 2001
Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replicationR Dummer, U Döbbeling, R Geertsen, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapyJ C Becker, R Dummer, A Schwinn, et al.Pageof 27